U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39 books (113 items)

1.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

2.
StatPearls [Internet].

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2026 Jan-.

3.
Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents.

Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 2000. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 76.)

4.
GeneReviews® [Internet].

GeneReviews® [Internet].

Adam MP, Bick S, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2026.

5.
Substance Abuse Treatment for Persons With HIV/AIDS [Internet].

Substance Abuse Treatment for Persons With HIV/AIDS [Internet].

Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2000. (Treatment Improvement Protocol (TIP) Series, No. 37.)

6.
Review of the Fialuridine (FIAU) Clinical Trials.

Review of the Fialuridine (FIAU) Clinical Trials.

Institute of Medicine (US) Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials; Manning FJ, Swartz M, editors.

Washington (DC): National Academies Press (US); 1995.

8.
Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses.

Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 1996. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 67.)

9.
Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities.

Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities.

Institute of Medicine (US) Committee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings; Curran J, Debas H, Arya M, et al., editors.

Washington (DC): National Academies Press (US); 2005.

10.
Regenerative Medicine.

Regenerative Medicine.

National Academy of Sciences (US).

Washington (DC): National Academies Press (US); 2003.

11.
No Time To Lose: Getting More from HIV Prevention.

No Time To Lose: Getting More from HIV Prevention.

Institute of Medicine (US) Committee on HIV Prevention Strategies in the United States; Ruiz MS, Gable AR, Kaplan EH, et al., editors.

Washington (DC): National Academies Press (US); 2001.

12.
Man-made Vitreous Fibres.

Man-made Vitreous Fibres.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 2002. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 81.)

14.
Molecular Imaging and Contrast Agent Database (MICAD) [Internet].

Molecular Imaging and Contrast Agent Database (MICAD) [Internet].

Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.

15.
16.
17.
Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks: Proceedings of a Workshop.

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks: Proceedings of a Workshop.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Global Health;Forum on Microbial Threats; Nicholson A, Minicucci C, Liao J, et al., editors.

Washington (DC): National Academies Press (US); 2022 Jan 11.

18.
Primary Care for Adults With HIV [Internet].

Primary Care for Adults With HIV [Internet].

Dyer M, Kerr C, Vail RM, et al.

Baltimore (MD): Johns Hopkins University; 2025 Mar.

19.
IRIS Toxicological Review of Formaldehyde (Inhalation) CASRN 50-00-0.

IRIS Toxicological Review of Formaldehyde (Inhalation) CASRN 50-00-0.

Kraft A, Bateson TF, Glenn B, et al.

Washington (DC): U.S. Environmental Protection Agency; 2024 Aug.

20.
Medical Microbiology. 4th edition.

Medical Microbiology. 4th edition.

Baron S, editor.

Galveston (TX): University of Texas Medical Branch at Galveston; 1996.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Images search in Bookshelf

  • Figure 1
  • Figure 1

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...